Seroprevalence in Tamil Nadu through India's two COVID waves: Evidence on antibody decline following infection and vaccination
Selvavinayagam, T. S.; Somasundaram, A.; Selvam, J. M.; Ramachandran, S.; P., S.; V., V.; C., A. B. K.; Subramanian, S.; Raju, S.; V., P.; N., Y.; Subramanian, G.; A., R.; D.N., D.; Imad, S.; Tandel, V.; Parasa, R.; Sachdeva, S.; Malani, A.
Show abstract
Four rounds of serological surveys were conducted, spanning two COVID waves (October 2020 and April-May 2021), in Tamil Nadu (population 72 million) state in India. Each round included representative populations in each district of the state, totaling [≥]20,000 persons per round. State-level seroprevalence was 31.5% in round 1 (October-November 2020), after Indias first COVID wave. Seroprevalence fell to 22.9% in 2 (April 2021), consistent with waning of antibodies from natural infection. Seroprevalence rose to 67.1% by round 3 (June-July 2021), reflecting infections from the Delta-variant induced second COVID wave. Seroprevalence rose to 93.1% by round 4 (December 2021-January 2022), reflecting higher vaccination rates. Antibodies also appear to wane after vaccination. Seroprevalence in urban areas was higher than in rural areas, but the gap shrunk over time (35.7 v. 25.7% in round 1, 89.8% v. 91.4% in round 4) as the epidemic spread even in low-density rural areas. Article Summary LineAntibodies waned after Indias first COVID wave and both vaccination and infection contributed its roughly 90% seroprevalence after its second wave.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- SARS-CoV-2 seroprevalence in Chattogram, Bangladesh before the Delta surge, March-June 2021 95%
- Longitudinal SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, during the first and second waves July 2020-March 2021 93%
- Modeling infections and deaths averted due to COVID-19 vaccination strategies in Ghana 92%
Similar papers in this journal
- The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide survey in Karnataka, India 94%
- Estimates of the global burden of Congenital Rubella Syndrome, 1996-2019 93%
- Country differences in transmissibility, age distribution and case-fatality of SARS-CoV-2: a global ecological analysis 93%
Similar papers in this journal
- The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: a cross sectional study 93%
- Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: repeated cross-sectional surveys 2020-21 93%
- Contact Tracing of COVID-19 in Karnataka, India: Superspreading and Determinants of Infectiousness and Symptomaticity 93%
Similar papers in this journal
- Health impact and cost-effectiveness of COVID-19 vaccination in Sindh Province, Pakistan 93%
- Global epidemiology of SARS-CoV-2 infection: a systematic review and meta-analysis of standardized population-based seroprevalence studies, Jan 2020-Dec 2021 92%
- Structural factors contributing to SARS-CoV-2 infection risk in the urban slum setting 92%
Similar papers in this journal
- All-cause excess mortality in the State of Gujarat, India, during the COVID-19 pandemic (March 2020-April 2021) 93%
- Drought, armed conflict and population mortality in Somalia, 2014-2018: a statistical analysis 93%
- High measles and rubella vaccine coverage and seroprevalence among Zambian children participating in a measles and rubella supplementary immunization activity 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.